Suppr超能文献

在健康超重和肥胖人群中,多功能饮食改善心血代谢风险标志物与肠道微生物类群有关。

Improvement in cardiometabolic risk markers following a multifunctional diet is associated with gut microbial taxa in healthy overweight and obese subjects.

机构信息

Department of Food Technology, Engineering and Nutrition, Lund University, Kemicentrum, Sölvegatan 39, SE-22100, Lund, Sweden.

InnovaFood AB, Äppelvägen 15, 247 47, Flyinge, Sweden.

出版信息

Eur J Nutr. 2018 Dec;57(8):2927-2936. doi: 10.1007/s00394-017-1563-3. Epub 2017 Nov 2.

Abstract

PURPOSE

A multifunctional diet (MFD) targeting subclinical inflammation was developed as a tool to decrease risk factors for cardiometabolic disease in healthy "at-risk" individuals (BMI 25-33 kg/m). MFD contains several components that are degraded in the colon by the microbiota, such as dietary fibers from rye, barley, oats and berries. It also contains soy beans, oily fish and plant stanols. In previous studies, we have observed improved cardiometabolic markers in healthy at-risk individuals after 4-8 week intake of MFD. However, whether these improvements can be associated with changes in the gut microbiota composition has not been investigated. In the present study, we analyzed the gut microbiota before and after an 8-week dietary intervention with MFD.

METHODS

Cardiometabolic at-risk individuals (n = 47), between 51 and 72 years old and with a BMI of 25-33 kg/m, were given either the MFD or a control diet lacking the functional ("active") components for 8 weeks in a parallel, randomized design. Next-generation sequencing of bacterial 16S rRNA genes was used to analyze the gut microbiota composition.

RESULTS

The 8-week intervention with MFD did not significantly alter the gut microbiota composition at phylum or genus taxonomic levels, while LEfSE analysis identified increased abundance of Prevotella copri in the MFD group as compared to the control group. Treponema correlated positively with blood pressure. In contrast, Faecalibacterium showed a negative association with blood pressure, while Bilophila appeared to associate with a negative blood lipid profile.

CONCLUSIONS

Taken together, results from the present study may be used in the further development of effective dietary concepts capable of reducing cardiometabolic risk markers in humans through a targeted modulation of the gut microbial community.

TRIAL REGISTRATION NUMBER

Clinical Trials.gov NCT02148653.

摘要

目的

开发了一种针对亚临床炎症的多功能饮食(MFD),作为降低代谢综合征风险因素的工具,适用于健康的“高危”个体(BMI 为 25-33kg/m)。MFD 包含几种成分,这些成分可在结肠中被微生物群降解,例如来自黑麦、大麦、燕麦和浆果的膳食纤维。它还包含大豆、油性鱼类和植物固醇。在之前的研究中,我们观察到健康高危个体在摄入 MFD 4-8 周后,代谢综合征相关标志物得到改善。然而,这些改善是否与肠道微生物群组成的变化有关,尚未进行研究。在本研究中,我们分析了 47 名代谢综合征高危个体在接受 8 周 MFD 饮食干预前后的肠道微生物群。

方法

代谢综合征高危个体(n=47),年龄在 51-72 岁之间,BMI 为 25-33kg/m,以平行、随机的设计分别给予 MFD 或缺乏功能性(“活性”)成分的对照饮食 8 周。采用细菌 16S rRNA 基因的下一代测序技术分析肠道微生物群组成。

结果

MFD 干预 8 周并未显著改变门或属分类水平的肠道微生物群组成,而 LEfSE 分析发现与对照组相比,MFD 组中普雷沃氏菌属的丰度增加。直肠真杆菌与血压呈正相关。相比之下,粪杆菌与血压呈负相关,而双岐杆菌似乎与血脂水平呈负相关。

结论

综上所述,本研究结果可用于进一步开发有效的饮食概念,通过靶向调节肠道微生物群落,降低人类代谢综合征风险标志物。

试验注册

ClinicalTrials.gov NCT02148653。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b66/6267413/ca0663bc09e4/394_2017_1563_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验